GoodRx (NASDAQ:GDRX) Sees Large Volume Increase - Here's What Happened

GoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) saw an uptick in trading volume on Friday . 670,223 shares traded hands during trading, an increase of 41% from the previous session's volume of 476,006 shares.The stock last traded at $4.45 and had previously closed at $4.56.

Analyst Upgrades and Downgrades

Several brokerages have commented on GDRX. Barclays decreased their price target on shares of GoodRx from $10.00 to $6.00 and set an "overweight" rating for the company in a research report on Monday, November 11th. Mizuho initiated coverage on GoodRx in a research note on Wednesday, December 4th. They set a "neutral" rating and a $5.00 target price for the company. Citigroup reduced their price target on GoodRx from $10.00 to $7.00 and set a "buy" rating on the stock in a research report on Wednesday, November 13th. Finally, Morgan Stanley reduced their target price on shares of GoodRx from $7.00 to $6.00 and set an "equal weight" rating on the stock in a report on Tuesday, December 17th. Five research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $8.64.

GoodRx Price Performance

The company has a debt-to-equity ratio of 0.70, a quick ratio of 5.48 and a current ratio of 5.48. The business's fifty day simple moving average is $4.94 and its 200 day simple moving average is $6.72. The stock has a market cap of $1.70 billion, a price-to-earnings ratio of -148.33, a price-to-earnings-growth ratio of 3.54 and a beta of 1.29.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the company. Rubric Capital Management LP raised its holdings in shares of GoodRx by 25.2% during the third quarter. Rubric Capital Management LP now owns 4,680,028 shares of the company's stock worth $32,479,000 after purchasing an additional 943,226 shares during the period. Millennium Management LLC grew its position in shares of GoodRx by 36.5% during the 2nd quarter. Millennium Management LLC now owns 4,121,939 shares of the company's stock valued at $32,151,000 after buying an additional 1,102,758 shares during the last quarter. American Century Companies Inc. acquired a new stake in GoodRx during the second quarter worth about $18,183,000. Point72 Asset Management L.P. bought a new position in GoodRx in the third quarter worth about $11,295,000. Finally, Geode Capital Management LLC boosted its stake in GoodRx by 6.3% in the third quarter. Geode Capital Management LLC now owns 982,729 shares of the company's stock valued at $6,823,000 after acquiring an additional 58,610 shares during the period. Institutional investors own 63.77% of the company's stock.

GoodRx Company Profile

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.